Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/1
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai)
Description: Subject matter under Class 424 definition which contains a designated organic active ingredient, e.g., coal tar, coal tar oil, etc.

Sub-classes under this class:

Class Number Class Name Patents
514/ Heterocyclic carbon cpmpounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai 0
514/149 Azoxy doai 54
514/150 Acyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide doai 288
514/152 3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) doai 329
514/155 Para-n-benzene - sulfoxy-n containing doai, and said benzene ring is not part of a polycyclo ring system 77
514/159 Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative doai 380
514/167 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin d, etc.) doai 707
514/169 Cyclopentanohydrophenanthrene ring system doai 611
514/183 Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai 2,142
514/2 Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai 7,690
514/22 Lignin or derivative doai 51
514/23 Carbohydrate (i.e., saccharide radical containing) doai 1,811
514/476 N-c(=x)x containing (x is chalcogen) doai 179
514/492 Heavy metal containing doai 681
514/506 Ester doai 329
514/553 Radical -xh acid, or anhydride, acid halide or salt thereof (x is chalcogen) doai 295
514/579 Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai 301
514/63 Silicon containing doai 1,033
514/64 Boron containing doai 255
514/65 Pyrethrum plant derived material or plant derived rotenone compound containing doai 96
514/675 Ketone doai 216
514/693 Aldehyde doai 172
514/706 Sulfur, selenium or tellurium compound (e.g., thioalcohols, mercaptans, etc.) 247
514/714 Peroxide doai 141
514/715 Ether doai 140
514/724 C-o-group (e.g., alcohol, alcoholate, etc.) doai 587
514/740 Nitrogen containing compound doai 149
514/743 Halogenated hydrocarbon doai 80
514/75 Phosphorus containing other than solely as part of an inorganic ion in an addition salt doai 320
514/762 Hydrocarbon doai 190

Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14

Patent Number Title Of Patent Date Issued
7700541 Biodegradable cationic polymers Apr. 20, 2010
7700542 Biodegradable cationic polymers Apr. 20, 2010
7700547 Preventing airway mucus production by administration of EGF-R antagonists Apr. 20, 2010
7700568 Uses of DNA-PK Apr. 20, 2010
7695678 Method of isolating nucleic acid using material positively charged at first pH and containing amino group and carboxyl group Apr. 13, 2010
7678775 ILK inhibitors for the treatment of renal disease Mar. 16, 2010
7674777 Immunostimulatory nucleic acid molecules Mar. 9, 2010
7666409 Low salt liquid seasoning with antihypertensive activity Feb. 23, 2010
7666829 Compositions for elastogenesis and connective tissue treatment Feb. 23, 2010
7662360 Conjugates of N-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds Feb. 16, 2010
7662767 Polynucleotide intercalator interceptors and inhibitors Feb. 16, 2010
7659082 Methods for identifying analgesic agents Feb. 9, 2010
7655472 Treatment of disease by inducing cell apoptosis Feb. 2, 2010
7655717 Ointment composition for treating decubitus ulcers and methods for its making and its use Feb. 2, 2010
7651687 Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors Jan. 26, 2010
7645732 Treating hepatitis C virus infection Jan. 12, 2010
7645464 Plant extracts Jan. 12, 2010
7645461 Method of treating cerebral ischemia with hydrogenation products of frankincense extracts Jan. 12, 2010
7645441 Compositions and methods in cancer associated with altered expression of PRLR Jan. 12, 2010
7632486 Method for diagnosing bone metastasis of malignant tumor Dec. 15, 2009
7632527 Compositions for juice-based peels and masks Dec. 15, 2009
7625718 SVCT2 transporters expressed in blood brain barrier cells Dec. 1, 2009
7622306 Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignan Nov. 24, 2009
7622453 Oligomeric compounds for the modulation of Bcl-2 Nov. 24, 2009
7618615 Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia Nov. 17, 2009
7611729 Dosage forms having prolonged active ingredient release Nov. 3, 2009
7611833 Yeast genes that affect viral replication Nov. 3, 2009
7601368 Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders Oct. 13, 2009
7592307 Releasable linkage and compositions containing same Sep. 22, 2009
7592319 Uses of DNA-PK Sep. 22, 2009
7589057 Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems Sep. 15, 2009
7589056 Agent for the prevention and treatment of sexually transmitted diseases-I Sep. 15, 2009
7588901 Modulation of angiogenesis through targeting of arginyl transferase (ATE1) Sep. 15, 2009
7582300 Modulation of gamma delta T cells to regulate airway hyperresponsiveness Sep. 1, 2009
7582317 Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof Sep. 1, 2009
7575767 Extraction of palm vitamin E, phytosterols and squalene from palm oil Aug. 18, 2009
7569536 Method for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity Aug. 4, 2009
7569551 Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides Aug. 4, 2009
7566454 Influenza nucleic acids, polypeptides, and uses thereof Jul. 28, 2009
7563618 Oligonucleotide conjugates Jul. 21, 2009
7560229 Methods of use of the enzymes of mycothiol synthesis Jul. 14, 2009
7547441 PAI-2 conjugates for the treatment and imaging of cancer Jun. 16, 2009
7547673 Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production Jun. 16, 2009
7534435 Glycosylated specificity exchangers May. 19, 2009
7534769 Compositions and methods for enhancing delivery of therapeutic agents to cells May. 19, 2009
7531499 Medicinal composition May. 12, 2009
7531500 Preventing airway mucus production by administration of EGF-R antagonists May. 12, 2009
7521414 Polyol macrolide antitumor-antibiotics from the marine actinomycete strain CNQ140 Apr. 21, 2009
7514397 Methods for inhibition of membrane-fusion-associated events, including Hepatitis B virus transmission Apr. 7, 2009
7507703 Method of cancer screening; method of cancer treatment; and method of diabetes treatment Mar. 24, 2009

1 2 3 4 5 6 7 8 9 10 11 12 13 14

  Recently Added Patents
Method and device for reducing image color noise
Push button
Establishing a graphical user interface (`GUI`) theme
Dynamic association and disassociation of threads to device functions based on requestor identification
Method and apparatus for a cryptographically assisted commercial network system designed to facilitate buyer-driven conditional purchase offers
Image reconstruction iterative method
Method and apparatus for complementing an instrument panel by utilizing augmented reality
  Randomly Featured Patents
Selective session interception method
Safety side-release belt buckle
Sample-and-hold device having input stages of amplifier coupled to capacitors
Sealing mechanism and method for screening machines
Multiple file system having a plurality of file units holding the same files in which loss of data is prevented in a failure of a file unit
Image forming apparatus having a movably supported transfer belt detector
Memory device having resistive element coupled to reference cell for improved reliability
Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
Colorimetric value calculating method, profile generating method, color conversion method, color conversion apparatus, and computer-readable recording medium with color conversion program reco
1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases